Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Antiparkinsonian agents and fluphenazine decanoate.

Idzorek S.

Am J Psychiatry. 1976 Jan;133(1):80-2.

PMID:
1247126
3.

Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.

MacCrimmon DJ, Saxena B, Foley P, Grof P.

Neuropsychobiology. 1978;4(6):360-5.

PMID:
692838
4.

Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.

Chouinard G, Annable L, Ross-Chouinard A.

Am J Psychiatry. 1982 Mar;139(3):312-8. No abstract available.

PMID:
6120655
5.

The long-acting phenothiazines.

Groves JE, Mandel MR.

Arch Gen Psychiatry. 1975 Jul;32(7):893-900.

PMID:
239663
6.

Unwanted effects of fluphenazine enanthate and decanoate.

Curry SH, Altamura AC, Montgomery S.

Lancet. 1979 Feb 10;1(8111):331-2. No abstract available.

PMID:
84989
7.

A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.

Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C.

Am J Psychiatry. 1994 Dec;151(12):1753-9.

PMID:
7977881
8.
9.

Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.

Gelenberg AJ, Doller JC, Schooler NR, Mieske M, Severe J, Mandel MR.

Am J Psychiatry. 1979 Feb;136(2):217-9. No abstract available.

PMID:
367182
10.

Depot fluphenazine decanoate and enanthate for schizophrenia.

David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000307. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD000307.

PMID:
15674872
11.

A comparative trail of fluphenazine decanoate and flupenthixol decanoate.

Haslam MT, Bromham BM, Schiff AA.

Acta Psychiatr Scand. 1975 Feb;51(2):92-100.

PMID:
1091124
12.

Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.

Carney MW, Sheffield BF.

Br J Psychiatry. 1976 Nov;129:476-81.

PMID:
990663
13.
14.
16.

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.

Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J.

Br J Psychiatry. 1991 May;158:658-65.

PMID:
1860020
17.

Fluphenazine enanthate in the outpatient treatment of late paraphrenia.

Raskind M, Alvarez C, Herlin S.

J Am Geriatr Soc. 1979 Oct;27(10):459-63.

PMID:
469146
18.

Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment.

Levinson DF, Simpson GM, Singh H, Yadalam K, Jain A, Stephanos MJ, Silver P.

Arch Gen Psychiatry. 1990 Aug;47(8):761-8.

PMID:
2378547
19.
20.

[Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].

Koślacz A, Popkowska N, Kulesza E, Lysikowska-Prokop L, Marmurowska-Michalowska H, Perzyński J.

Psychiatr Pol. 1977 Mar-Apr;11(2):159-64. Polish. No abstract available.

PMID:
887674

Supplemental Content

Support Center